Fluorescence based assay to detect sodium/calcium exchanger (NCX) "reverse mode" modulating compounds

Details for Australian Patent Application No. 2009226681 (hide)

Owner Sanofi-Aventis

Inventors Frey, Manfred; Licher, Thomas; Geibel, Sven

Agent Watermark

Pub. Number AU-A-2009226681

PCT Pub. Number WO2009/115238

Priority 08290265.1 20.03.08 EP

Filing date 13 March 2009

Wipo publication date 24 September 2009

International Classifications

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/115238 Priority application(s): WO2009/115238

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009226682-Fluorescence based assay to detect sodium/calcium exchanger "forward mode" modulating Compounds

2009226680-Selected salts of 3-(5,6-dihydro-1,4,2-dioxazine-3-yl)-N-[( 4,6dimethoxypyrimidine2-yl)carbamoyl]pyridine-2-sulfonamide, method for the production thereof, and use thereof as herbicides and plant growth regulators